drugset / Trial / NCT03960671

Therapeutic Drug Monitoring of Anxiolytics in Children

NCT03960671

Phase 4 Unknown 500 enrolled Wei Zhao
NaSingle-groupOpen-labelOther

Summary

In this study, the therapeutic drug monitoring of anxiolytics is carried out among children to obtain the drug concentration, clinical efficacy and safety data of children patients in different gender and age groups. Then the investigators analyze the relationship between blood drug concentration and efficacy and safety, and provide recommendations for the treatment window of anxiolytics in Chinese children.

Timeline

Start
2018-08-01
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule
Subject Midazolam Small molecule
Subject Propofol Small molecule

Indications

No indication recorded.